This study is aimed to characterize Russian population of Usher patients.
This study is aimed to characterize Russian population of Usher patients. Tasks: Stage 1. Formation of the primary cohort of patients. Patients pre-recruiting will be performed based on Deaf-Blind Support Foundation "Con-nection" patient database analysis. Patients with clinically confirmed Usher syndrome will be evaluated according to available data of the clinical examination. Stage 2. Clinical examination of patients. Each patient will undergo the following diagnostic procedures according to the unified protocol: * Visometry (with correction and without correction) * Ophthalmoscopy * Perimetry * Optical coherence tomography * Electroretinography * Visually evoked potentials * Refractometry * Pneumotonometry * Biomicroscopy * Tonal audiometry * Electronic audiometry (ASSR test) * Acoustic impedance measurement * Vestibulometry * Electronystagmography * Any additional examinations and consultations if necessary Medical record will be developed and maintained for each patient consisting results of extended clinical examination. Stage 3. Genetic study of patients. All enrolled patients will undergo single 4 ml peripheral venous blood sampling. DNA will be extracted from leucocytes. DNA samples will be analyzed and placed for long-term storage in liquid nitrogen. Statistical and bioinformatic analysis of detected genetic mutations in the study cohort will be performed.
Study Type
OBSERVATIONAL
Enrollment
28
Federal State Budgetary Institution "Research Center for Medical Genetics"
Moscow, Russia
Deaf-Blind Support Foundation "Con-nection"
Moscow, Russia
State Research Center Burnasyan Federal Medical Biophysical Center Federal Medical-Biological Agency
Moscow, Russia
Scientific and Clinical Center for Otorhinolaryngology of FMBA of Russia
Moscow, Russia
Changes in visual acuity
Measured by visometry
Time frame: Up to 4 weeks
Changes in structures of fundus of the eye-1
Measured by ophthalmoscopy
Time frame: Up to 4 weeks
Changes in structures of fundus of the eye-2
Measured by optical coherence tomography
Time frame: Up to 4 weeks
Changes in visual field
Measured by perimetry
Time frame: Up to 4 weeks
Changes in retinal ganglion cell dysfunction
Measured by electroretinography
Time frame: Up to 4 weeks
Changes in brain visual cortex neural pathways
Measured by visually evoked potentials
Time frame: Up to 4 weeks
Changes in optical refraction
Measured by refractometry
Time frame: Up to 4 weeks
Changes in intraocular pressure
Measured by pneumotonometry
Time frame: Up to 4 weeks
Changes in the lens, cornea, anterior segment of the eye
Measured by biomicroscopy
Time frame: Up to 4 weeks
Changes in hearing-1
Measured by tonal audiometry
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Oftalmic LLC
Moscow, Russia
Autonomous nonprofit organization "Scientific and industrial laboratory "Sensor technology for deafblind"
Moscow, Russia
Time frame: Up to 4 weeks
Changes in hearing-2
Measured by electronic audiometry (ASSR test)
Time frame: Up to 4 weeks
Changes in efficient sound transmission in the middle ear
Measured by acoustic impedance measurement
Time frame: Up to 4 weeks
Changes in vestibular functions
Measured by vestibulometry
Time frame: Up to 4 weeks
Changes in vestibular reactions
Measured by electronystagmography
Time frame: Up to 4 weeks